PMID: 9547353May 9, 1998Paper

Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in Hep G2 cells

Molecular Pharmacology
Q Chen, Arthur I Cederbaum

Abstract

Two Hep G2 subclones overexpressing CYP2E1 were established with the use of transfection and limited dilution screening techniques. The Hep G2-CI2E1-43 and -47 (E47) cells (transduced Hep G2 subclones that overexpress CYP2E1) grew at a slower rate than parental Hep G2 cells or control subclones that do not express CYP2E1, but remained fully viable. When GSH synthesis was inhibited by treatment with buthionine sulfoximine, GSH levels rapidly declined in E47 cells but not control cells, which is most likely a reflection of CYP2E1-catalyzed formation of reactive oxygen species. Under these conditions of GSH depletion, cytotoxicity and apoptosis were found only with the E47 cells. Low levels of lipid peroxidation were found in the E47 cells, which became more pronounced after GSH depletion. The antioxidants vitamin E, vitamin C, or trolox prevented the lipid peroxidation as well as the cytotoxicity and apoptosis, as did transfection with plasmid containing antisense CYP2E1 or overexpression of Bcl-2. Levels of ATP were lower in E47 cells because of damage to mitochondrial complex I. When GSH was depleted, oxygen uptake was markedly decreased with all substrates in the E47 extracts. Vitamin E completely prevented the decrease in oxy...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Feb 1, 1979·Journal of Cellular Physiology·J M HarmonE B Thompson
Oct 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T CastilloH Tsukamoto
Jan 6, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D R Koop
Jan 1, 1992·Free Radical Biology & Medicine·R NordmannH Rouach
Mar 1, 1991·Chemical Research in Toxicology·F P GuengerichM Iwasaki
Aug 1, 1991·Molecular Endocrinology·L A Caron-Leslie, J A Cidlowski
Sep 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H TsukamotoS W French
Sep 1, 1990·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·D R Koop, D J Tierney
Jan 1, 1990·Drug Metabolism Reviews·C S YangJ Y Hong
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A D VazM J Coon
Feb 1, 1989·Alcoholism, Clinical and Experimental Research·A A NanjiS W French
Dec 1, 1974·Archives of Biochemistry and Biophysics·A I CederbaumE Rubin
Oct 22, 1993·Cell·D M HockenberyS J Korsmeyer
Jul 6, 1995·Nature·M Whyte, G Evan
Nov 1, 1994·Proceedings of the Society for Experimental Biology and Medicine·M MorimotoS W French
Jan 1, 1994·The Journal of Cell Biology·J C Reed
Aug 30, 1996·The Journal of Biological Chemistry·A KrippnerB M Babior
Sep 27, 1996·The Journal of Biological Chemistry·D Wu, A I Cederbaum
May 1, 1997·Archives of Biochemistry and Biophysics·M X Yang, A I Cederbaum

❮ Previous
Next ❯

Citations

Sep 22, 1999·Molecular and Cellular Biology·Y MorelR Barouki
Sep 25, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N NietoA I Cederbaum
Feb 15, 2001·Journal of Biomedical Science·M MaríA I Cederbaum
Jan 5, 2002·International Journal of Cancer. Journal International Du Cancer·Maja KrajinovicDaniel Sinnett
Jun 6, 2003·Immunopharmacology and Immunotoxicology·Robyn E Arnold, Douglas A Weigent
Jun 5, 2003·The Journal of Biological Chemistry·Pengfei GongNatalia Nieto
Nov 24, 2004·Drug Metabolism Reviews·Donald J Reed
Dec 29, 2005·The Journal of Biological Chemistry·Jingxiang Bai, Arthur I Cederbaum
Nov 25, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Defeng Wu, Arthur I Cederbaum
Mar 4, 2006·The Journal of Pharmacology and Experimental Therapeutics·Aparajita Dey, Arthur I Cederbaum
Apr 1, 2008·Experimental Biology and Medicine·Zhanxiang ZhouY James Kang
Dec 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Natalia NietoArthur I Cederbaum
Jun 19, 2003·The Journal of Biological Chemistry·Andres A Caro, Arthur I Cederbaum
Jan 13, 2001·The Journal of Biological Chemistry·E P Neve, M Ingelman-Sundberg
Sep 2, 2005·American Journal of Physiology. Cell Physiology·Chris E P GoldringB Kevin Park
Mar 23, 2006·The Journal of Biological Chemistry·Pengfei Gong, Arthur I Cederbaum
Jun 11, 2004·Journal of Neurochemistry·Niclas TindbergYin Hu
Oct 6, 2005·Alcoholism, Clinical and Experimental Research·Raj LakshmanTerrence M Donohu
Oct 28, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Yongke Lu, Arthur I Cederbaum
Oct 27, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Natalia A OsnaTerrence M Donohue
May 21, 2008·Laboratory Investigation; a Journal of Technical Methods and Pathology·Osvaldo R KochGiovambattista Pani
Sep 9, 2006·Journal of Gastroenterology and Hepatology·Arthur I Cederbaum
Jun 3, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ying WangHelmut K Seitz
May 19, 2009·Archives of Toxicology·Arthur I CederbaumDefeng Wu
Jun 19, 2012·British Journal of Clinical Pharmacology·Richard KiaChris E P Goldring
May 27, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Rajat SinghMark J Czaja
Mar 30, 2011·PloS One·Mahendra Pratap KashyapAditya Bhushan Pant
Jun 1, 2008·Expert Opinion on Drug Discovery·Andrew L NilesTerry L Riss
Mar 25, 2017·International Journal of Oncology·Lu LiYanyan Liu
Jul 23, 2003·Journal of Cellular Biochemistry·Hiroyuki TanakaYukio Fujimoto
May 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·María José Pérez, Arthur I Cederbaum
Dec 12, 2003·World Journal of Gastroenterology : WJG·Jian ZhugeYing-Nian Yu
Jul 9, 2004·International Journal of Cancer. Journal International Du Cancer·Jenny C HoSheung Tat Fan
Apr 21, 2006·The Journal of Pharmacology and Experimental Therapeutics·Andres A Caro, Arthur I Cederbaum
Jun 18, 2009·World Journal of Gastroenterology : WJG·Giovanni TarantinoDomenico Capone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Pharmacology and Experimental Therapeutics
Aparajita Dey, Arthur I Cederbaum
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
María José Pérez, Arthur I Cederbaum
© 2022 Meta ULC. All rights reserved